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Research
In recent years low-molecular-weight serum
protein profiling has become increasingly
important in detecting early events in the dis-
ease process and predicting outcomes. The
recent use of this technique to detect ovarian
cancer provided a great impetus to this field
(Petricoin et al. 2002). Both SELDI-TOF
(surface-enhanced laser desorption/ioniza-
tion–time of flight) and MALDI-TOF
(matrix-assisted laser desorption/ionization–
time of ﬂight) mass spectrometry (Hutchens
and Yip 1993; Karas and Hillenkamp 1988;
Karas et al. 1987; Tang et al. 2004) are prov-
ing to be powerful tools for diagnosing disease
states, particularly for early detection of can-
cer, through the analysis of proteomic pat-
terns. When combined with bioinformatic
tools, protein proﬁling has become an effec-
tive approach in screening for potential tumor
markers (Rai et al. 2002). 
Because bronchoalveolar lavage fluid
(BALF) exhibits the cellular and biochemical
alterations of inflammation and lung injury
in response to various toxic agents, perfor-
mance of a proteomic analysis of BALF to
characterize the effects of diesel exhaust parti-
cles (DEPs) exposure is warranted. We previ-
ously designed a neural network program for
the analysis of proteomic patterns in serum
samples of humans exposed to various levels
of DEPs (unpublished data). These studies
showed the potential for proteomics to dis-
criminate occupational exposures to various
deleterious agents and prompted the valida-
tion study presented here. 
DEP exposure induces the production of
cytokines in lung epithelial cells in vitro
(Bayram et al. 1998; Steerenberg et al. 1998)
and in lung tissue in vivo (Saber et al. 2006).
It also affects the lipopolysaccharide-induced
production of cytokines (tumor necrosis
factor-α and interleukin-1) in alveolar
macrophages (AMs; Yang et al. 1997, 1999).
We previously studied the expression of the
mRNA levels for several of these cytokines
and correlated these observations with the
inﬂammatory response as assessed by measur-
ing the influx of cells and protein into the
bronchoalveolar space. In addition, cytokine
levels were measured in BALF. The results
showed that DEPs up-regulate several genes
implicated in the inﬂammatory response, both
at the message and protein levels, within 24 hr
in cells obtained from BALF, representing the
inﬂux of both polymorphonuclear leukocytes
(PMNs) and AMs (Rao et al. 2005). 
In this study, we used newly available pro-
teomic technologies to characterize the
changes in protein concentrations caused 
by DEP exposure. We used a Ciphergen
ProteinChip System and liquid chromatogra-
phy coupled to mass spectrometry (LC/MS)
to characterize the samples. In the Ciphergen
system, protein samples are allowed to adsorb
to spots on a ﬁxed support with a speciﬁc sur-
face chemistry. Unbound proteins are washed
off the chip, and the remaining bound pro-
teins are ionized with a laser, and their masses
are characterized by time of ﬂight mass spec-
trometry. For LC/MS, polypeptide mixtures
are digested with trypsin; the peptides are
bound to a chromatographic column, eluted
with a continuous gradient of acetonitrile and
ionized by electrospray directly into either a
time of ﬂight or ion-trap mass spectrometer.
Using a weak cationic exchange ProteinChip,
protein profiling was performed on BALF
taken from rats at 1, 7, or 30 days after expo-
sure to various concentrations of DEPs. This
approach was complemented by global analy-
sis using LC/MS to determine protein identity
and to broadly screen for qualitative differ-
ences. We found DEP exposure–induced
changes in the abundance of a number of pro-
teins using a SELDI methodology. These and
additional proteins identified by LC/MS are
indicative of tissue damage and inﬂammation.
Materials and Methods
Animals. Research was conducted in compli-
ance with the Animal Welfare Act (1966), and
other federal statutes and regulations relating
to animals and experiments involving animals
and adheres to principles stated in the Guide
for the Care and Use of Laboratory Animals
(National Research Council 1996) in facilities
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BACKGROUND: Inhalation of diesel exhaust particles (DEPs) is characterized by lung injury and
inﬂammation, with signiﬁcant increases in the numbers of polymorphonuclear leukocytes and alve-
olar macrophages. This influx of cellular infiltrates is associated with the activation of multiple
genes, including cytokines and chemokines, and the production of reactive oxygen species. 
OBJECTIVE: The pathogenesis of the lung injury is not fully understood, but alterations in the pres-
ence or abundance of a number of proteins in the lung have been observed. Our objective in this
study was to further characterize these changes and to ask whether additional changes could be dis-
cerned using modern proteomic techniques.
METHODS: The present study investigates global alterations in the proteome of bronchoalveolar lavage
ﬂuid taken from rats 1, 7, or 30 days after exposure to 5, 35, or 50 mg/kg of animal weight of DEPs. 
RESULTS: Analysis by surface-enhanced laser desorption/ionization–time of ﬂight mass spectrome-
try identiﬁed two distinct peaks that appeared as an acute response postexposure at all doses in all
animals. We identiﬁed these two peaks, with mass to charge ratios (m/z) of 9,100 and 10,100, as
anaphylatoxin C3a and calgranulin A by additional mass spectral investigation using liquid chro-
matography coupled to mass spectrometry. 
CONCLUSIONS: With this approach, we found a number of inflammatory response proteins that
may be associated with the early phases of inflammation in response to DEP exposure. Further
studies are warranted to determine whether serum levels of these proteins could be markers of
diesel exhaust exposure in workers.
KEY WORDS: calprotectin, diesel, inflammation, macrophage, mass spectrometry, proteomics,
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http://dx.doi.org/ [Online 5 February 2007]fully accredited by the Association for the
Assessment and Accreditation of Laboratory
Animal Care, International. The animals were
treated humanely and with regard for allevia-
tion of suffering. The animals used in these
experiments were speciﬁc pathogen-free male
Sprague-Dawley rats [Hla:(SD)CVF; Hilltop
Laboratories, Scottdale, PA], weighing
250–275 g (approximately 8 weeks old) at
arrival. The rats were housed at the National
Institute for Occupational Safety and Health
animal facility, under temperature and
humidity controlled conditions and a 12-hr
light/dark cycle. The rats were monitored to
be free of endogenous viral pathogens, para-
sites, mycoplasmas, Helicobacter, and CAR
(cilia-associated respiratory) bacillus. Rats
were acclimated for at least 5 days before use
and were housed in ventilated cages, which
were provided with HEPA-ﬁltered air. Alpha-
Dri virgin cellulose chips (Shepherd Speciality
Papers, Watertown, TN) and hardwood Beta
chips (NEPCO, Warrenburg, NY) were
used as bedding. ProLab 3500 diet (Harlan
Teklad, Madison, WI) and tap water were
provided ad libitum.
Reagents. DEPs were from a National
Institute of Standards and Technology stan-
dardized heavy-duty diesel engine emission
sample (no. 1650) with an average mass
median diameter of 0.5 µm.
Experimental design. Animals were
exposed by intratracheal (IT) instillation with
a single dose of either saline, or DEPs.
Groups of animals (n = 4 per group), repre-
senting each treatment, were sacriﬁced at 1, 7,
and 30 days after exposure to obtain BALF.
Intratracheal instillation of DEPs. DEPs
were suspended in endotoxin, Ca2+ and
Mg2+ free phosphate-buffered saline (PBS;
BioWhittaker, Walkersville, MD) and soni-
cated for 1 min. Rats were anesthetized with an
intraperitoneal (ip) injection of 30–40 mg/kg
body weight sodium methohexital (Brevital;
Eli Lilly and Co., Indianapolis, IN) and were
intratracheally instilled using a 20-ga, 4-inch
ball-tipped animal feeding needle. Rats were
given 5, 35, or 50 mg DEP/kg body weight or
an equivalent volume of PBS. IT instillation
has been shown to be a valid model to study
pathological changes associated with airborne
pollutants and is considered particularly useful
in elucidating mechanisms of response
(Henderson et al. 1995).
BAL ﬂuid. Rats were anesthetized with an
overdose of sodium pentobarbital (100 mg/kg
body weight) and exsanguinated. The trachea
was cannulated, and the lungs were lavaged.
BALF was obtained by a single lavage using
cold Ca2+- and Mg2+-free PBS containing
5.5 mM D-glucose. The ﬁrst lavage return of
approximately 6 mL was centrifuged to sedi-
ment cells at 300 × g. The acellular supernatant
was transferred to plastic tubes and stored at
–80°C. Every effort was made to minimize
protein degradation by avoiding multiple
freeze–thaw cycles. Samples analyzed by
SELDI-TOF were thawed only once. At times
additional processing of samples, such as weak
cation exchange (WCX)-extraction, required
refreezing of aliquots.
Proteomic patterns. Proteomic patterns
were obtained using the WCX2 ProteinChip
on the Ciphergen ProteinChip System
(Ciphergen Biosystems, Inc., Fremont, CA).
WCX2 chips were equilibrated with 2× bind-
ing buffer [50 mM ammonium acetate
(NH4OAc) and 0.01% Triton X-100 at
pH 6.0]. BALF samples were diluted 2-fold
with binding buffer, and 200 µL was placed on
a WCX2 chip in the bioprocessor and allowed
to incubate for 1 hr. Chips were washed with
binding buffer and water before drying and the
addition of the sinapinic acid (SPA). Data col-
lection was optimized for the mass to charge
ratio (m/z) range of 3,000–50,000, with a
detector sensitivity of 7, a laser intensity of
150 and a high m/z of 50,000. The data pre-
sented in the ﬁgures have been baseline sub-
tracted using Ciphergen’s ProteinChip
software with a window of 25 points for the
option to smooth before ﬁtting baseline and
with the automatic option for parameters.
Protein identification. Protein samples
from a control rat and a rat 24 hr postexposure
to the high dose were subjected to further
analysis to identify the proteins associated with
the peaks observed in the SELDI-TOF data.
To mimic WCX2 chemistry, a solid-phase
extraction (SPE) was performed with the BALF
using a WCX resin, Biosepra CM Ceramic
HyperD F (Pall Corp., East Hills, NY). The
resin was equilibrated with 1× binding buffer.
BALF was diluted with 2× binding buffer (1×
ﬁnal concentration) and mixed with the resin.
The resin with bound BALF proteins was
washed with 0.5 M NH4OAc to remove pro-
teins with a low binding afﬁnity, then proteins
of interest were eluted with 2 M NH4OAc.
Eluted proteins were separated using a
NuPAGE 4–12% BisTris gel in an MES
Running Buffer (Invitrogen Corp., Carlsbad,
CA) and stained with SyproRuby (Bio-Rad
Laboratories, Hercules, CA). Protein bands in
the appropriate relative molecular weight range
were manually excised, reduced with 5 mM
dithiothreitol (DTT) and alkylated with
50 mM iodoacetamide (Bio-Rad Laboratories),
digested with trypsin (Promega Corp.,
Madison, WI) and eluted by diffusion. After
concentration by evaporation in a Speed Vac
Concentrator (Eppendorf, Westbury, NY),
samples were resuspended, and an aliquot of
each elution was modified with imidazole to
enhance ionization. Imidazole was part of the
Lys Tag kit (Agilent Technologies, Palo Alto,
CA) and used according to manufacturer’s 
recommendations. Both labeled and unlabeled
samples were analyzed on an Agilent SL 
ion trap mass spectrometer connected to 
an Agilent 1100 nanoflow HPLC (Agilent
Technologies). 
As a secondary validation of identifica-
tion, WCX-extracted proteins and whole
BALF were analyzed by direct LC/MS (not
gel based) on a Waters Q-Tof Premier
quadrupole time-of-flight mass spectrometer
(QTOF) in tandem with a nanoACQUITY
ultra performance liquid chromatograph
(UPLC) system (Waters Corp., Milford,
MA). Before LC/MS, the samples were
lyophilized and resuspended in 50 mM
ammonium bicarbonate, 5 mM DTT and
0.05% RapiGest (Waters Corp.). After denat-
uration at 80°C, proteins were alkylated with
25 mM iodoacetamide and digested overnight
with trypsin. The samples were diluted to a
ﬁnal RapiGest concentration of 0.025%. For
the whole BALF, a tryptic digestion of the
proteins was separated into eight fractions
using an Agilent 1100 HPLC before analysis
on the QTOF. In lieu of traditional tandem
MS (MS/MS), QTOF data were collected
using the Waters Protein Expression method.
Three technical replicates were performed for
each of the samples.
Protein Expression method. This is a
novel method of data acquisition and analysis
designed by Waters to maximize information
content gained from mass spectral analysis
(Hughes et al. 2006; Silva et al. 2006). In this
method, spectra are collected alternating
between low- and high-collision energies;
no selective mass filtering is performed.
Therefore, fragmentation data are collected
for every precursor ion and are not limited by
the number of MS/MS scans that can be per-
formed in a single run. Furthermore, the
intensity of each precursor ion is collected
across its entire peak, so quantitative data are
maximized. The fragment ions in the high-
energy scans are assigned to precursor ions
based on elution proﬁles using computational
methods. The collection of fragment ions is
combined into a synthetic spectrum (termed
MSE, where E signiﬁes energy) that is used for
database searches. 
LC parameters. Peptides extracted from
gel spots were separated using an Agilent
1100 HPLC coupled to the Agilent SL ion
trap mass spectrometer. The 8-µL injection
volume was trapped on a 0.3 × 5–mm Zorbax
SB C-18 column using 3% acetonitrile
(MeCN) and 0.1% formic acid at a ﬂow rate
of 20 µL/min for 16 min. A 75-µm × 50-mm
Zorbax SB C-18 column, 3.5-µm particle size
(Agilent Technologies), was used for analyti-
cal separation with a ﬂow rate of 300 nL/min.
The gradient profile was 3% MeCN for
16 min, 10% MeCN at 23 min, 35% MeCN
at 43 min, 80% MeCN at 48.5 min until
58.5 min, and 3% MeCN at 63 min until
Proteomic analysis of BAL fluid
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used throughout. 
Initial fractionation of whole BALF pep-
tides was performed using a combination of
anion and cation exchange columns on an
Agilent 1100 HPLC. A Polycat A 200 ×
4.6 mm, 5 µm, 300-Å column and Polywax 
LP 100 × 4.6 mm, 5 µm, 1,000-Å column
(PolyLC Inc., Columbia, MD) were connected
in series for the separation. The injection 
volume was 100 µL and the column tempera-
ture was 35°C. The gradient proﬁle was from
20 mM NH4OAc to 1.8 M NH4OAc in
9 min and held constant until stopping at
17 min; 10% MeCN was used throughout.
Time-based fractions were collected starting at
2.1 min. A 1-min fraction and four 30-sec and
three 1-min fractions were collected in order.
Samples were dried and resuspended in 100 µL
of 3% MeCN, 0.1% formic acid.
WCX-extracted BALF and fractionated
whole BALF were separated using the Waters
nanoACQUITY UPLC system coupled to a
Q-Tof Premier mass spectrometer. The injec-
tion volume of 10 µL was trapped using a
180 µm × 20 mm Waters Symmetry C18,
5-µm particle size column using 0.1% formic
acid at a ﬂow rate of 5 µL/min for 4 min. The
analytical separation was performed using a
75 µm × 100 mm Waters nanoACQUITY
UPLC BEH C18 column, 1.7-µm particle
size. The column temperature was 35°C. The
gradient profile was 3% MeCN for 1 min,
30% MeCN at 101 min, 60% MeCN at
105 min, 80% MeCN at 111 min, and 3%
MeCN at 112 min until stopping at 130 min;
0.1% formic acid was maintained throughout.
The flow rate was 300 nL/min for the
extracted BALF samples and the ﬁrst fraction
of whole BALF. The ﬂow rate was reduced to
250 nL/min because of high back pressure for
the remaining fractions.
Ion trap parameters. Peptides were ionized
in positive ion mode. Ion charge control was
used with a target of 75,000 counts and a max-
imum accumulation time of 300 msec. Three
precursors were selected based on intensity
with an absolute threshold of 1,000 counts.
Active exclusion was used and precursors were
released after 1 min. The MS/MS fragmenta-
tion amplitude was set at 1.2 V. 
QTOF parameters. Peptides were ionized
in positive ion mode. Data were collected
over the m/z 50–1,900 range for 0.8 sec/scan.
Scans were performed with the collision cell
voltage set at 10 V for low-energy scans and
ramped from 20 to 40 V during high-energy
scans. [Glu1]-ﬁbrinopeptide B was used as an
external lock mass for accurate mass calcula-
tions (m/z 785.8426). A 1-sec lock mass scan
was collected every 30 sec.
Database searches. All searches were
performed against an in-house rat database
containing the entire rat RefSeq protein data-
base (National Center for Biotechnology
Information; www.ncbi.nlm.nih.gov; down-
loaded 01 March 2006) supplemented with
sequences of potentially contaminating pro-
teins, including human keratins, bovine serum
albumin (BSA), and trypsin. To control for
false positives, random sequences were included
in the database. The number, length, and
amino acid frequency of the random sequences
are equal to those of the downloaded sequences. 
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Figure 1. (A) SELDI-TOF mass spectra of BALF obtained at 24 hr post-treatment from four control rats (PBS
instilled) and four rats exposed intratracheally to 50 mg DEP/kg body weight and (B) a zoomed view of two spec-
tra generated by averaging the data from the four control or four exposed replicates. max, maximum. Peaks at
9,100 and 10,100 are detected only in the spectra from the exposed samples. The peak near 13,100 is also pre-
sent only in exposed samples but is undoubtedly only above baseline when multiple spectra are averaged.
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using DataAnalysis 2.2 (Agilent Technologies).
Mascot 2.1 (Matrix Science, Boston, MA) was
used for searching with following modifica-
tions enabled: ﬁxed carbamidomethyl (C) and
variable oxidation (M), oxidation (HW), phos-
pho (STY), sodiated (C-term), and sodiated
(DE). A variable imidazole modiﬁcation was
also enabled when appropriate. Under these
conditions, the 95% confidence level for an
individual peptide match corresponded to
Mowse scores ranging from 50 to 54.
The QTOF data were submitted as raw
data to Protein Lynx Global Server 2.2
(PLGS; Waters Corp.) and processed using
the Protein Expression method. The only
modiﬁcation enabled in PLGS searches was a
fixed carbamidomethyl (C). To limit the
number of false positives, we considered only
protein identiﬁcations with conﬁdence levels
≥ 0.99. When multiple isoforms of the same
protein were identiﬁed that shared numerous
identical peptides and could not be distin-
guished, the conﬁdence levels were summed,
and a single protein was reported with multi-
ple accession numbers. Protein identiﬁcations
determined by direct LC/MS were reported
only if they were found in all three technical
replicates of at least one condition and had
identifications for at least three unique pep-
tides. Despite these rigid criteria, we found
that when combining the peak lists from all
the LC/MS runs from the fractionated
BALF, there was an unacceptably high false
positive rate (as determined by the number of
random sequence hits). The scoring algo-
rithm used in PLGS appears to overestimate
the relevance of numerous, low-quality hits.
The effect is pronounced only in large data
sets, where presumably the total number of
peaks increases the chances that multiple
incorrectly identiﬁed peptides may be attrib-
uted to the same protein in the database. To
control for this, we developed a second scor-
ing criterion using the average score per pep-
tide and the average score for the top five
highest scoring peptides. Only protein identi-
fications with an average score per peptide
> 2.7 or average of the top ﬁve peptides > 10
were considered to be high-quality hits.
These values were set at a level that limited
the false positive rate to < 5% in single repli-
cates and allowed no detectable false positives
when the replicate ﬁlter was used. 
Results
Figure 1A shows the SELDI-TOF spectra of
BALF using a WCX2 ProteinChip obtained
from four control and four DEP-exposed ani-
mals at 50 mg/kg body weight. When com-
pared with the mass spectra from the control
animals, the spectra from the DEP-exposed
animals show two additional peaks with m/z
values of approximately 9,100 and 10,100.
These peaks appear in samples from all the
exposed doses at 24 hr but are not seen in
day 7 and day 30 samples (data not shown).
This ﬁnding indicates that these peaks repre-
sent an acute response to DEP exposure that
resolves in a few days.
To identify these proteins, we fractionated
BALF from rats 24 hr postexposure by SPE
using a WCX resin with subsequent denatur-
ing polyacrylamide gel electrophoresis
(SDS-PAGE). Four predominant bands are
observed in exposed samples in the low-
molecular-weight region of the gel where the
proteins corresponding to the peaks of inter-
est from the SELDI-TOF data would be
expected to migrate (Figure 2). These gel
bands were excised; the protein contained in
them was digested, eluted, and analyzed by
LC/MS technology using an ion trap mass
spectrometer. The uppermost band (Figure 2,
band 4) is present at approximately the same
concentration in both exposed and unexposed
samples and was identiﬁed as lysozyme. The
two lowest bands (Figure 2, bands 1 and 2)
likely correspond to the SELDI-TOF peaks
with m/z 9,100 and 10,100 and were identi-
fied by database searches as anaphylatoxin
C3a and calgranulin A. We could not identify
the protein from the middle band (Figure 2,
Proteomic analysis of BAL fluid
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Figure 2. Gel electrophoresis of extracted BALF
obtained at 24 hr posttreatment from a control rat
(PBS instilled) and a rat exposed intratracheally to
50 mg of DEP/kg body weight. The four numbered
bands in the diesel lane were excised and analyzed
by LC/MS.
21.5
14.4
6.5
MW (kDa) Diesel Control
4
3
2
1
Table 1. Gel band identiﬁcation of proteins corresponding to SELDI-TOF peaks.a
Gel High No.  of
band scoreb spectra Processingc Sequence Modiﬁcationsd Proteine
1 6 1 IMID ILLQGTPVAQMAEDAVDGERLK C3
1 56 2 IMID LITQGESCLK IMID C3a
1 34 1 AFMDCCNYITK ox-Met C3a
1 34 1 LITQGESCLK C3a
1 87 6 MVTTECPQFVQNK ox-Met cal A
1 66 1 MVTTECPQFVQNK cal A
2 3 1 IMID FGLEKR C3
2 11 1 IMID ARLITQGESCLK IMID C3a
2 79 6 IMID LITQGESCLK IMID C3a
2 64 3 AFMDCCNYITK ox-Met C3a
2 59 6 LITQGESCLK C3a
2 64 1 MVTTECPQFVQNK ox-Met cal A
aProtein bands excised from an SDS-PAGE gel (Figure 2) from BALF sample taken 24 hr postexposure were digested and
analyzed by LC-MS/MS on an ion trap mass spectrometer. Peptide identifications were determined using Mascot.
bHighest score for an individual spectrum from the Mascot search for the indicated peptide. cAn aliquot of each sample
was labeled with imidazole before MS analysis to enhance ionization. This indicates whether the identiﬁcation was in a
modiﬁed or unmodiﬁed sample. dModiﬁcations identiﬁed by Mascot search (IMID–imidazole or ox-Met–oxidated methio-
nine). eProtein identiﬁcations are complement C3, anaphylatoxin C3a, or calgranulin A (cal A). 
Table 2. LC/MS identiﬁcation of proteins corresponding to SELDI-TOF peaks.a
Replicate Condition Peak (m/z) Score Unique peptides Protein
1 Exposed 9,100 58.9 3 Calgranulin A
2 Exposed 9,100 49.0 4 Calgranulin A
3 Exposed 9,100 51.3 4 Calgranulin A
1 Exposed 10,100 51.8 25 Complement C3
1 Exposed 10,100 60.5 33 XP_579384
2 Exposed 10,100 39.8 26 Complement C3
2 Exposed 10,100 38.7 26 XP_579384
3 Exposed 10,100 107.5 29 XP_579384
1 Exposed 13,200 43.4 3 Calgranulin B
2 Exposed 13,200 53.0 7 Calgranulin B
3 Exposed 13,200 30.8 4 Calgranulin B
1 Exposed 5,000b, 7,500,15,000 107.0 7 Lysozyme
2 Exposed 5,000b, 7,500,15,000 61.3 6 Lysozyme
3 Exposed 5,000b, 7,500,15,000 120.8 7 Lysozyme
1 Unexposed 5,000b, 7,500,15,000 56.4 5 Lysozyme
2 Unexposed 5,000b, 7,500,15,000 58.0 5 Lysozyme
3 Unexposed 5,000b, 7,500,15,000 92.9 8 Lysozyme
aProteins were extracted using a weak cation exchange resin from BALF obtained at 24 hr posttreatment from a control
rat (PBS instilled) and a rat exposed intratracheally to 50 mg of DEP/kg body weight. Tryptic digests of the proteins were
analyzed on a QTOF using the Protein Expression method and identiﬁed using PLGS. bThe m/z of 5,000 and 7,500 corre-
sponds to triply- and doubly-charged lysozymes.band 3, Mr = 10–15 kDa) by analysis of the
excised gel slice. A small peak corresponding
to its relative molecular weight is detectable in
the SELDI-TOF data with an m/z just above
13,000. However, it is only distinctly above
noise level when multiple spectra are averaged
(Figure 1B). 
Two predominant peptides (Table 1) from
the SDS-PAGE-excised bands formed the
basis for the identification of anaphylatoxin
C3a, which is a proteolytically processed
product of complement C3. Two peptides
present in complement C3 but not in ana-
phylatoxin C3 were identified, suggesting
that complement C3 or partially cleaved C3
might be present. However, we believe that
the identification of these peptides as C3
sequences is artifactual because they were the
two lowest scoring peptide matches in the
search (scores = 3 and 6), their scores were
below statistical significance, and they were
only found in imidazole-labeled samples, even
though neither peptide has this modiﬁcation.
We conclude that the presence of naturally
processed anaphylatoxin C3a is the most
likely explanation for the presence of comple-
ment C3 peptides.
SPE-fractionated BALF was also analyzed
directly by LC/MS (no SDS-PAGE) using a
QTOF and the Waters Protein Expression
method, and the presence of calgranulin-A
was conﬁrmed (Table 2). Complement C3 or
a C3 isoform (XP_579384), 98% identical to
C3 overall and 100% identity in the anaphy-
latoxin C3a region) was also identified, but
since proteins are digested with trypsin before
LC/MS analysis, the full-length and processed
proteins are indistinguishable. Additionally,
this technique provided a possible protein
identification for the previously unidentified
band (Figure 2, band 3) and the small
SELDI-TOF peak at 13,000 (Figure 1B), cal-
granulin B. 
A total of 65 proteins were identified by
performing LC/MS analysis of whole BALF
and WCX-extracted BALF (Table 3) on a
QTOF using the Waters protein expression
method. Each reported protein was identiﬁed
in all three technical replicates of at least one
of the conditions. We compared the lists of
confirmed proteins and unfiltered search
results to identify possible missed or lower
scoring identiﬁcations. The quality of the iden-
tiﬁcation of each protein in each condition was
assigned in one of four ranks: a) high-quality
identiﬁcations in all three replicates, b) a high-
quality identiﬁcation in at least one replicate,
c) a low-quality identification in at least one
replicate, and d) not identiﬁed. The majority
of the proteins (41) were seen in both control
and exposed samples, whereas 20 were identi-
ﬁed only in diesel-exposed samples and 4 were
identiﬁed only in control samples. 
The predominant peaks found in the
SELDI-TOF spectra have all been identiﬁed
(Figure 3). Lysozyme (Lyz) is quite abundant
in these samples and appears as singly, dou-
bly, and triply charged peaks (m/z 15,000,
7,500, and 5,000, respectively). Two of these
(Figure 3; Lyz 1+ and Lyz 2+) are the largest
peaks in all the samples and do not change as
a result of exposure. Two readily observable
peaks, seen only in spectra from the diesel-
exposed, 24-hr samples, represent anaphyla-
toxin C3a and calgranulin A, and a third
Lewis et al.
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Table 3. LC/MS identiﬁcation of proteins in BALF from rats.a
GenInfo no.b Description Gene symbol  Originc WCX_Dd Diesel WCX_C Control Founde
27229290 afamin Afm Plasma — +++ — +++ Both
19705431 albumin Alb Plasma +++ +++ + +++ Both
83816939  alpha 1 inhibitor III  Mug1
62648373  alpha 1 inhibitor III  Mug1 Plasma — +++ — +++ Both 
62647940  alpha 1 inhibitor III  Mug1
12831225 alpha 1 inhibitor III  Mug1
6978477 alpha 2 HS glycoprotein Ahsg Plasma ++ +++ + +++ Both
34867677 alpha-1-antichymotrypsin  Serpina3m Plasma — +++ — +++ Both
51036655 alpha-1-antitrypsin Serpina1 Plasma — +++ — +++ Both
58865630 antithrombin-III Serpinc1 Plasma — ++ — +++ Both
6978515 apolipoprotein A I Apoa1 Plasma — +++ — +++ Both
57528174 apolipoprotein H Apoh Plasma +++ +++ — +++ Both
57529187 carboxylesterase, esterase 2 Es2 Leukocytes — +++ — +++ Both
6978695 ceruloplasmin Cp Plasma — +++ — +++ Both
61657901 chitinase 3 like 1 Chi3l1 Leukocytes ++ + — +++ Both
47059181 complement B factor Cfb Plasma +++ +++ +++ +++ Both
47575877 complement component 2 C2 Plasma + +++ — + Both
8393024  complement component 3 C3 Plasma +++ +++ +++ +++ Both
62718645 complement component 3 C3
29789265 complement component 4a C4a Plasma +++ — — +++ Both
54234046 cystatin C Cst3 Leukocytes — +++ — ++ Both
17865327 fetuin beta Fetub Plasma — +++ — +++ Both
29789106 ﬁbrinogen beta polypeptide Fgb Plasma +++ + — +++ Both
51854227 gelsolin Gsn Plasma +++ +++ + — Both
6978879 group speciﬁc component Gc Plasma — +++ — +++ Both
60097941 haptoglobin Hp Plasma ++ +++ + +++ Both
17985949 hemoglobin beta chain Hbb Blood ++ +++ — +++ Both
16758014 hemopexin Hpx Plasma +++ +++ + +++ Both
62651518 immunoglobulin heavy chain like Plasma + +++ — + Both
9506819 inter alpha inhibitor H4 heavy chain Itih4 Plasma + + — +++ Both
80861401 kininogen 1 Kng1 Plasma — +++ — +++ Both
40254796 lysozyme Lyz Lung +++ +++ +++ +++ Both
25282393 mast cell peptidase 2  mcpt2 Leukocytes — +++ + — Both
27465565 Niemann Pick type C2 Npc2 Leukocytes — +++ + ++ Both
62638541 plasminogen Plg Plasma ++ +++ — +++ Both
21955142 pregnancy zone protein Pzp Plasma +++ +++ — +++ Both
6981694 secretoglobin family 1A Scgb1a1 Lung — +++ + ++ Both
18266692 selenium binding protein 2 Selenbp1 Lung — +++ — ++ Both
Continued, next pagepeak, whose signal is only slightly above
noise, is also present only in spectra from
exposed, 24-hr samples and was identiﬁed as
calgranulin B.
Discussion
Diesel exhaust particles are generated by
heavy-duty diesel engines used in many
industries and motor vehicles used in public
transportation. They are respirable particles
with an average diameter of 250 nm and
contain several mutagenic and carcinogenic
hydrocarbons (Arlt et al. 2003). Epidemiologic
and experimental animal studies have shown
an increased risk of respiratory and cardiovas-
cular morbidity and mortality associated with
exposure to DEPs (Rai et al. 2002; Salvi
2001; Steerenberg et al. 1998). They also
cause adverse reactions in the lungs (Diaz-
Sanchez et al. 1994) and other tissues
(Yoshino and Sagai 1999). DEP exposure
induces production of cytokines in AMs
(Yang et al. 1997, 1999), in lung epithelial
cells, and in lung tissue (Bayram et al. 1998;
Saber et al. 2006; Steerenberg et al. 1998).
Within 24 hr after exposure to DEPs, quan-
tifiable changes in cytokines, an influx of
inﬂammatory cells and proteins, and up-regu-
lation of gene expression of inflammatory
mediators are observable in BALF from
exposed rats (Rao et al. 2005). 
The aim of this study was to characterize
the changes in protein proﬁles in the BALF of
rats following DEP exposure using newly
available proteomic technologies. This was
accomplished using two complementary tech-
nologies, SELDI-TOF and LC/MS. The spectra
obtained using a Ciphergen ProteinChip
System contain two readily observable peaks
and a third weak peak that are specific to
BALF samples taken from rats 24 hr after
exposure to DEPs. Subsequent analysis using
LC/MS indicates that the proteins producing
these peaks are calgranulin A, calgranulin B,
and anaphylatoxin C3a. 
An additional 62 proteins present in
BALF were also identiﬁed through the utiliza-
tion of Waters’s LC/MS protein expression
technology. Twenty (20) proteins, most of
which are lung damage and inflammation
speciﬁc, were repeatedly identiﬁed only in the
exposed sample. Presumably, they are more
abundant in this sample, as there is a strong
bias toward identification of the proteins at
the highest concentrations using LC/MS.
Four proteins were identified in the control
sample but not in the exposed one. The
abundance of these proteins may have been
reduced in BALF from exposed animals.
However, the presence of these proteins
may also simply have been masked in the
exposed sample by the higher amount of total
protein in it. 
There is a large difference in total protein
levels between the two samples, with the
higher protein concentration in the exposed
sample likely a result of plasma extravasation.
Consistent with this view, many of the
plasma-derived proteins identified in both
samples do indeed change in abundance [for
example, albumin (Rao et al. 2005 and
unpublished data)], but additional work will
be required to provide accurate quantifica-
tion. A quantitative comparison using the
Protein Expression method was confounded
Proteomic analysis of BAL fluid
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Table 3. Continued.
GenInfo no.b Description Gene symbol Originc WCX_Dd Diesel WCX_C Control Founde
32563565 serine protease inhibitor 2a Spin2a Plasma — +++ — +++ Both
6981576 serine protease inhibitor 2b Spin2b Plasma — +++ — +++ Both
13928716 serine protease inhibitor 2c Serpina3n Plasma ++ +++ — +++ Both
20301980 surfactant associated protein B Sftpb Lung — +++ — +++ Both
7949133 surfactant associated protein D Sftpd Lung +++ +++ +++ +++ Both
62654137 transferrin Tf Plasma +++ +++ +++ +++ Both 
61556986 transferrin Tf
62654202 transferrin like Plasma — +++ — ++ Both
16758048 advanced glycosylation end product-speciﬁc receptor  Ager Lung — +++ — — DEP
6978501 annexin A1 Anxa1 Lung — +++ — — DEP
6978505 annexin A5 Anxa5 Lung — +++ — — DEP
34861019 calcium activated chloride channel Clca3 Lung — +++ — — DEP
16758672 calgranulin A S100a8 Leukocytes +++ — — — DEP
16758364 calgranulin B S100a9 Leukocytes +++ — — — DEP
62078741 coagulation factor XII F12 Plasma +++ — — — DEP
77861917 complement component factor H Cfh Plasma +++ ++ — — DEP
25742583 defensin beta 3 Defb3 Lung — +++ — — DEP
62643670 ﬁbrinogen alpha polypeptide Fga Plasma +++ — — — DEP
56797757 ﬁbrinogen alpha polypeptide Fga
62657833  histidine rich glycoprotein Hrg Plasma +++ — — — DEP
19173806 histidine rich glycoprotein Hrg
62079255 immunoglobulin heavy chain like Plasma — +++ — — DEP
62660301 immunoglobulin joining chain Igj Plasma — +++ — — DEP
25282405 palate lung and nasal epithelium carcinoma associated protein Plunc Lung — +++ — — DEP
16758348 peroxiredoxin 6 Prdx6 Lung — +++ — — DEP
27151742 polymeric immunoglobulin receptor Pigr Lung — +++ — — DEP
62660728 SEC14 like 3 Sec14l3 Lung — +++ — — DEP
8394337 surfactant pulmonary-associated protein A1 Sftpa1 Lung — +++ — — DEP
6981684 transthyretin Ttr Plasma +++ — — — DEP
27465549 WAP four disulﬁde core domain 2 Wfdc2 Lung — +++ — — DEP
19705570 angiotensinogen Agt Plasma — — — +++ Cont
8393197 C reactive protein Crp Plasma — — — +++ Cont
62658037 carboxypeptidase N regulatory subunit Cpn2 Plasma — — — +++ Cont
40018558 complement component 1 inhibitor Serping1 Plasma — — — +++ Cont
aTryptic digests of proteins from BALF obtained at 24 hr posttreatment from a control rat (PBS instilled) and a rat exposed intratracheally to 50 mg of DEP/kg body weight were analyzed
on a QTOF using the Protein Expression method and identified using PLGS. bThe GI number is a unique GenInfo identifier for the protein sequence in the NCBI’s GenBank database
(www.ncbi.nlm.nih.gov). cProbable origins of proteins. dThe quality of identiﬁcation for each protein in each sample was categorized into one of four levels: high-scoring identiﬁcations
in all three technical replicates (+++), a high-scoring identiﬁcation in at least one replicate (++), a low-scoring identiﬁcation in at least one replicate (+), or no identiﬁcation (—). Columns
represent SPE extracted diesel or control samples (WCX_D or WCX_C, respectively) or whole BALF from diesel or control samples. eIndicates whether proteins were identified in
exposed, unexposed, or both samples (DEP, Cont, or Both, respectively).by ion-suppression effects and challenges in
normalization resulting from the large differ-
ence in total protein concentrations. Because
we prefer to interpret the data conservatively,
we have not reported this “quantitative” data. 
A side note to the LC/MS analysis is that
different sets of proteins were identiﬁed in the
SPE samples and in the whole BALF. The
largest hindrances to protein identification
by mass spectrometry are sample complexity
and dynamic range. The WCX extraction
addresses both of these by reducing the con-
centration of the most abundant protein
(albumin) and reducing the total number of
proteins present. This is why proteins that are
“hidden” in whole BALF can be identiﬁed in
SPE samples. 
Based on the proteins identified, the
major observed effect of DEP exposure
appears to be an inflammatory response.
Anaphylatoxin C3a, a component of the
complement system, is a well-known media-
tor of inflammation [see Ember and Hugli
(1997) for a review], and calgranulin A is a
part of a hetero-dimer with calgranulin B (also
known as MRP-8 and MRP-14, respectively)
that make up calprotectin. Calprotectin is cur-
rently used as a biomarker of inflammation
for several human diseases. It is primarily
expressed in PMNs and is estimated to
account for 30–60% of their cytosolic and
5% of their total proteins. Furthermore, the
level of calprotectin at sites of inflammation
is known to correlate with the number of
localized PMNs [reviewed in Striz and
Trebichavsky (2004); Yui et al. 2003], and
we have previously shown that exposure to
DEPs causes an increase in the PMN content
of BALF at 24 hr (Rao et al. 2005). The
presence of an inﬂammatory response is fur-
ther supported by the qualitative analysis of
the proteins identiﬁed by LC/MS.
Many of the proteins that we have
observed in both the exposed and unexposed
sample are highly abundant in the plasma
and are present as a result of plasma extrava-
sation. However, DEP-exposed samples show
a pronounced increase in the amount and
number of proteins observed, which appears
to be caused by damage at the air–blood
barrier that is a result of DEP exposure (Rao
et al. 2005). Without analysis of the plasma,
it is not possible to discriminate changes in
concentration of plasma-derived proteins that
are present because of extravasation from
those that are specific to the inflammatory
responses.
On the technical side, it is worth noting
that the discovery of anaphylatoxin C3a in
the SELDI-TOF data demonstrates an advan-
tage to a top-down proteomics approach.
LC/MS analysis of digested proteins is unable
to distinguish processed and unprocessed
complement C3. The SDS-PAGE analysis
conﬁrmed the SELDI-TOF data but required
significantly more effort to acquire the data.
Protein modiﬁcations, such as the cleavage of
complement C3, can play major biological
roles and are important to characterize.
However, it must be noted that the top-down
approach used in this work is not a global
analysis, as only proteins that bind with high
afﬁnity to a weak cation exchange chip were
retained. The WCX2 chip was chosen
because of its low afﬁnity for serum albumin,
which is abundant in BALF; in the future the
analysis could be extended by using chips
supporting other surface chemistries. Another
caveat was that this approach only detected
large acute changes and was unable to discern
difference at later time points. Since it is
known that the lungs have not returned to
normal (Rao et al. 2005), it is likely that the
method was not sensitive enough or does not
have sufﬁcient dynamic range to identify the
lower abundance proteins that are perturbed
at 7 or 30 days postexposure. In the current
state of proteomic technology, a combination
of complementary strategies is required to
maximize proteome coverage.
The protein expression method used in
this study provides more complete coverage
than the SELDI-TOF and was chosen over a
traditional LC-MS/MS approach because it is
more suited for comparative analyses. This
method of fragmentation provides more
reproducible coverage because all the ions are
fragmented each run, and the identiﬁed pep-
tides are not limited by which precursor ions
are select for tandem MS. Furthermore, since
only one fragmented ion scan is performed for
each survey scan, there is far more quantitative
data for the parent ions. This being said, two
noteworthy shortcomings were identified
with this approach. The scoring algorithm
used for database searches needs to be opti-
mized. We addressed the issue by removing
proteins that were identified as the result of
multiple low scoring peptide hits, but ideally
such ﬁltering should be handled in the initial
search. There is no easy way to normalize or
to account for ion suppression resulting from
samples with large difference in protein abun-
dance, such as the unexposed and exposed
BALF samples. 
In summary, we demonstrate that it is
possible to detect markers of inflammation
after diesel exhaust particulate exposure in the
BALF using the Ciphergen ProteinChip
System. Additional mass spectrometric inves-
tigation using liquid chromatography coupled
to mass spectrometry (LC/MS) was used to
identify the predominant peaks present in the
SELDI-TOF spectra and also provided an
additional list of proteins that change in
response to exposure. Further studies are
required to see if these markers are detectable
in serum samples from animals or humans
exposed to diesel exhaust. 
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